Literature DB >> 2348451

Effect of repeated measurements of blood pressure on blood pressure in essential hypertension: role of anxiety.

A McGrady1, J T Higgins.   

Abstract

Over the past years, we repeatedly observed that of the hypertensive population entered into our behavioral treatment programs, more than half were actually false hypertensives. With repeated measurements of blood pressure (BP), only one-third remained hypertensive, while two-thirds showed a significant decrease in BP. The purpose of this study was to determine which factors correlate with the decrease in BP and could be useful in distinguishing the true and the false hypertensives. Of the 24 patients in this study, 15 decreased their mean arterial pressure by at least 5 mm Hg during a 6-week period of home and clinic BP measurement, while 9 did not. The 9 patients with BPs that did not change had lower State Anxiety, Trait Anxiety scores, lower diastolic BP, and lower heart rates compared to the group whose BPs decreased. These results suggest that under certain conditions a relationship exists between anxiety and elevated blood pressure. In a segment of the hypertensive population, anxious patients may be placed on inappropriate antihypertensive medication if a BP measurement period is not conducted before intervention.

Entities:  

Mesh:

Year:  1990        PMID: 2348451     DOI: 10.1007/bf00844901

Source DB:  PubMed          Journal:  J Behav Med        ISSN: 0160-7715


  17 in total

1.  The 1988 report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure.

Authors: 
Journal:  Arch Intern Med       Date:  1988-05

2.  How common is white coat hypertension?

Authors:  T G Pickering; G D James; C Boddie; G A Harshfield; S Blank; J H Laragh
Journal:  JAMA       Date:  1988-01-08       Impact factor: 56.272

Review 3.  Behavioral medicine: symbiosis between laboratory and clinic.

Authors:  N E Miller
Journal:  Annu Rev Psychol       Date:  1983       Impact factor: 24.137

4.  Expectation and the blood-pressure-lowering effects of relaxation.

Authors:  W S Agras; M Horne; C B Taylor
Journal:  Psychosom Med       Date:  1982-09       Impact factor: 4.312

5.  Relation of state and trait anxiety to essential hypertension.

Authors:  G D Foster; S T Bell
Journal:  Psychol Rep       Date:  1983-04

6.  The effect of biofeedback-assisted relaxation training on blood pressure and selected biochemical parameters in patients with essential hypertension.

Authors:  A V McGrady; R Yonker; S Y Tan; T H Fine; M Woerner
Journal:  Biofeedback Self Regul       Date:  1981-09

7.  Behavioral treatment of high blood pressure. I. Analyses of intra- and interdaily variations of blood pressure during a one-month, baseline period.

Authors:  B T Engel; K R Gaarder; M S Glasgow
Journal:  Psychosom Med       Date:  1981-06       Impact factor: 4.312

8.  Effect of biofeedback-assisted relaxation on blood pressure and cortisol levels in normotensives and hypertensives.

Authors:  A McGrady; M Woerner; G A Bernal; J T Higgins
Journal:  J Behav Med       Date:  1987-06

9.  Anger and anxiety in borderline hypertension.

Authors:  R H Schneider; B M Egan; E H Johnson; H Drobny; S Julius
Journal:  Psychosom Med       Date:  1986 Mar-Apr       Impact factor: 4.312

10.  Psychologic differences between high-, normal-, and low-renin hypertensives.

Authors:  S A Thailer; R Friedman; G A Harshfield; T G Pickering
Journal:  Psychosom Med       Date:  1985 May-Jun       Impact factor: 4.312

View more
  2 in total

1.  Effects of group relaxation training and thermal biofeedback on blood pressure and related physiological and psychological variables in essential hypertension.

Authors:  A McGrady
Journal:  Biofeedback Self Regul       Date:  1994-03

Review 2.  The Relationship Between Psychosocial Status and Hypertensive Condition.

Authors:  Ștefania Matei; Stephen J Cutler; Marian Preda; Maria Dorobanțu; Corina Ilinca; Oana Gheorghe-Fronea; Luminița Rădulescu; Nicoleta Oprescu; Alexandru Deaconu; Corina Zorilă; Bogdan Dorobanțu
Journal:  Curr Hypertens Rep       Date:  2018-10-25       Impact factor: 5.369

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.